Crewe Advisors LLC
- SEC CIK
- 0001730033
- Latest filing
- Jul 23, 2026
FDMT holding history
4D Molecular Therapeutics, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −142−100.0% | Sold out | Holders |
| Q1 2023 | 142 | $2.44K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 142 | $3.15K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 142 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 142 | $1.00K | <0.1% | +142 | New | Holders |